These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33755013)

  • 1. Allosteric communication in class A β-lactamases occurs via cooperative coupling of loop dynamics.
    Galdadas I; Qu S; Oliveira ASF; Olehnovics E; Mack AR; Mojica MF; Agarwal PK; Tooke CL; Gervasio FL; Spencer J; Bonomo RA; Mulholland AJ; Haider S
    Elife; 2021 Mar; 10():. PubMed ID: 33755013
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Barnes MD; Winkler ML; Taracila MA; Page MG; Desarbre E; Kreiswirth BN; Shields RK; Nguyen MH; Clancy C; Spellberg B; Papp-Wallace KM; Bonomo RA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
    Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Ω-Loop in Regulation of the Catalytic Activity of TEM-Type β-Lactamases.
    Egorov A; Rubtsova M; Grigorenko V; Uporov I; Veselovsky A
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31835662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication between the active site and the allosteric site in class A beta-lactamases.
    Meneksedag D; Dogan A; Kanlikilicer P; Ozkirimli E
    Comput Biol Chem; 2013 Apr; 43():1-10. PubMed ID: 23314151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric inhibition of TEM-1 β lactamase: Microsecond molecular dynamics simulations provide mechanistic insights.
    Hellemann E; Nallathambi A; Durrant JD
    Protein Sci; 2023 Apr; 32(4):e4622. PubMed ID: 36906819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of long-distance mutations on the Ω-loop conformation in TEM type β-lactamases.
    Shcherbinin D; Veselovsky A; Rubtsova M; Grigorenko V; Egorov A
    J Biomol Struct Dyn; 2020 May; 38(8):2369-2376. PubMed ID: 31241429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations Utilize Dynamic Allostery to Confer Resistance in TEM-1 β-lactamase.
    Modi T; Ozkan SB
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl-enzyme conformational dynamics to extend antibiotic resistance.
    Tooke CL; Hinchliffe P; Bonomo RA; Schofield CJ; Mulholland AJ; Spencer J
    J Biol Chem; 2021; 296():100126. PubMed ID: 33257320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study.
    Krishnan NP; Nguyen NQ; Papp-Wallace KM; Bonomo RA; van den Akker F
    PLoS One; 2015; 10(9):e0136813. PubMed ID: 26340563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.
    Palzkill T
    Front Mol Biosci; 2018; 5():16. PubMed ID: 29527530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of conformational dynamics determines the conversion of a promiscuous generalist into a specialist enzyme.
    Zou T; Risso VA; Gavira JA; Sanchez-Ruiz JM; Ozkan SB
    Mol Biol Evol; 2015 Jan; 32(1):132-43. PubMed ID: 25312912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and biochemical characterization of the interaction between KPC-2 beta-lactamase and beta-lactamase inhibitor protein.
    Hanes MS; Jude KM; Berger JM; Bonomo RA; Handel TM
    Biochemistry; 2009 Oct; 48(39):9185-93. PubMed ID: 19731932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interdomain flexibility and interfacial integrity of β-lactamase inhibitory protein (BLIP) modulate its binding to class A β-lactamases.
    Huang L; So PK; Chen YW; Leung YC; Yao ZP
    J Biol Chem; 2021 Aug; 297(2):100980. PubMed ID: 34302811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
    Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
    Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.
    Chow DC; Rice K; Huang W; Atmar RL; Palzkill T
    ACS Infect Dis; 2016 Dec; 2(12):969-979. PubMed ID: 27756125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
    Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saturation Mutagenesis and Molecular Modeling: The Impact of Methionine 182 Substitutions on the Stability of β-Lactamase TEM-1.
    Grigorenko VG; Krivitskaya AV; Khrenova MG; Rubtsova MY; Presnova GV; Andreeva IP; Serova OV; Egorov AM
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.